The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

For decades, the United States has led the world in pharmaceutical innovation – developing drugs that combat cancer, heart ...

The end of compounded versions of weight-loss drugs is near, leaving patients scrambling for alternatives. Some “copycat” ...

FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 – glucagon-like peptide-1 receptor agonists – drugs, including semaglutide and tirzepatide, as an ...

In December, the FDA removed tirzepatide, the active ingredient in Zepbound, from the shortage list. Many compounders had to stop producing weight-loss drugs “that are essentially a copy of ...

ABC News' Dr. Tara Narula shares what patients need to know. Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U ...

On March 5, 2025, the U.S. District Court for the Northern District of Texas denied the Outsourcing Facilities Association’s motion for a ...

If you’d like to notify the FDA about a side effect you’ve had with Zepbound, visit MedWatch. If you’re calling on behalf of someone else, stay with them until help arrives. You may remove ...

The future of American drug innovation is threatened by US regulations that permit knockoff versions of new drugs to be sold to US consumers.

The U.S. Food and Drug Administration (FDA) will now begin restricting the creation of the compound drugs. In 2022, the popularity of weight-loss drugs was rising too quickly for drug companies to ...

Larger outsourcing pharmacies making compound versions of Zepbound have until March 19 to stop, according to the FDA. State-licensed pharmacies must stop making most compounded semaglutide (copies ...